# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 19, "Curr Med Res Opin .", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasJournal> \"Curr Med Res Opin .\"."
1, PublicationYear, 20, 24, "2009", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasPublicationYear> \"2009\"."
2, Title, 92, 232, "Three - month , randomized , parallel - group comparison of brimonidine - timolol versus dorzolamide - timolol fixed - combination therapy .", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasTitle> \"Three - month , randomized , parallel - group comparison of brimonidine - timolol versus dorzolamide - timolol fixed - combination therapy .\"."
3, Duration, 92, 105, "Three - month", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasCTduration> \"Three - month\"."
4, Randomized, 108, 118, "randomized", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
117, Parallel, 121, 137, "parallel - group", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
120, Brimo/TimFC, 152, 173, "brimonidine - timolol", "", 
6, Brimonidine, 152, 163, "brimonidine", "", 
7, Timolol, 166, 173, "timolol", "", 
123, Dorz/TimFC, 181, 222, "dorzolamide - timolol fixed - combination", "", 
8, Dorzolamide, 181, 192, "dorzolamide", "", 
9, Timolol, 195, 202, "timolol", "", 
10, Author, 233, 241, "Nixon DR", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasAuthor> \"Nixon DR\"."
11, Author, 250, 256, "Yan DB", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasAuthor> \"Yan DB\"."
12, Author, 259, 271, "Chartrand JP", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasAuthor> \"Chartrand JP\"."
13, Author, 274, 287, "Piemontesi RL", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasAuthor> \"Piemontesi RL\"."
14, Author, 290, 299, "Simonyi S", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasAuthor> \"Simonyi S\"."
15, Author, 302, 314, "Hollander DA", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasAuthor> \"Hollander DA\"."
145, Brimo/TimFC, 406, 443, "0 . 2 % brimonidine - 0 . 5 % timolol", "", 
17, DoseValue, 406, 411, "0 . 2", "", 
18, Percentage, 412, 413, "%", "", 
6, Brimonidine, 414, 425, "brimonidine", "", 
22, DoseValue, 428, 433, "0 . 5", "", 
19, Percentage, 434, 435, "%", "", 
7, Timolol, 436, 443, "timolol", "", 
146, Dorz/TimFC, 448, 481, "2 % dorzolamide - 0 . 5 % timolol", "", 
23, DoseValue, 448, 449, "2", "", 
20, Percentage, 450, 451, "%", "", 
8, Dorzolamide, 452, 463, "dorzolamide", "", 
24, DoseValue, 466, 471, "0 . 5", "", 
21, Percentage, 472, 473, "%", "", 
9, Timolol, 474, 481, "timolol", "", 
25, IOP, 500, 520, "intraocular pressure", "", 
26, IOP, 523, 526, "IOP", "", 
156, ObjectiveDescription, 531, 783, "The objective of this study was to evaluate the IOP - lowering efficacy and ocular tolerability of brimonidine - timolol compared with dorzolamide - timolol when used as monotherapy or as adjunctive therapy to a prostaglandin analog ( PGA ) in patients", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasObjectiveDescription> \"The objective of this study was to evaluate the IOP - lowering efficacy and ocular tolerability of brimonidine - timolol compared with dorzolamide - timolol when used as monotherapy or as adjunctive therapy to a prostaglandin analog ( PGA ) in patients\"."
27, IOP, 579, 582, "IOP", "", 
150, Brimo/TimFC, 630, 651, "brimonidine - timolol", "", "<http://ctro/data#Medication_102724> <http://ctro/data#hasDrug> <http://ctro/data#Brimo/TimFC>."
6, Brimonidine, 630, 641, "brimonidine", "", 
7, Timolol, 644, 651, "timolol", "", 
153, Dorz/TimFC, 666, 687, "dorzolamide - timolol", "", "<http://ctro/data#Medication_102731> <http://ctro/data#hasDrug> <http://ctro/data#Dorz/TimFC>."
8, Dorzolamide, 666, 677, "dorzolamide", "", 
9, Timolol, 680, 687, "timolol", "", 
92856, ProstaglandinAnalogs, 743, 763, "prostaglandin analog", "", 
92857, ProstaglandinAnalogs, 766, 769, "PGA", "", 
88009, Precondition, 775, 820, "patients with glaucoma or ocular hypertension", "", "<http://ctro/data#Population_74566> <http://ctro/data#hasPrecondition> \"patients with glaucoma or ocular hypertension\"."
157, ObjectiveDescription, 784, 822, "with glaucoma or ocular hypertension .", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasObjectiveDescription> \"with glaucoma or ocular hypertension .\"."
28, Glaucoma, 789, 797, "glaucoma", "", "<http://ctro/data#Glaucoma_74550> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glaucoma>. <http://ctro/data#ClinicalTrial_74541> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Glaucoma_74550>."
29, OcularHypertension, 801, 820, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
30, Randomized, 878, 888, "randomized", "", 
31, Blind, 891, 912, "investigator - masked", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
32, Duration, 915, 924, "3 - month", "", 
161, Parallel, 927, 943, "parallel - group", "", 
34, Multicenter, 979, 988, "ten sites", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
35, NumberPatientsCT, 1002, 1005, "180", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasNumberPatientsCT> \"180\"."
36, OpenAngleGlaucoma, 1020, 1041, "open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma>."
37, OcularHypertension, 1045, 1064, "ocular hypertension", "", 
38, IOP, 1091, 1094, "IOP", "", 
88010, DeliveryMethod, 1104, 1111, "topical", "", 
173, Brimo/TimFC, 1112, 1133, "brimonidine - timolol", "", 
6, Brimonidine, 1112, 1123, "brimonidine", "", 
7, Timolol, 1126, 1133, "timolol", "", 
39, Frequency, 1134, 1137, "BID", "", "<http://ctro/data#Intervention_102712> <http://ctro/data#hasFrequency> \"BID\"."
174, Dorz/TimFC, 1141, 1162, "dorzolamide - timolol", "", 
8, Dorzolamide, 1141, 1152, "dorzolamide", "", 
9, Timolol, 1155, 1162, "timolol", "", 
40, Frequency, 1163, 1166, "BID", "", "<http://ctro/data#Intervention_102718> <http://ctro/data#hasFrequency> \"BID\"."
43, NumberPatientsArm, 1188, 1191, "101", "", "<http://ctro/data#Arm_74579> <http://ctro/data#hasNumberPatientsArm> \"101\"."
92858, ProstaglandinAnalogs, 1224, 1227, "PGA", "", 
44, Latanoprost, 1230, 1241, "latanoprost", "", 
45, Bimatoprost, 1244, 1255, "bimatoprost", "", 
46, Travoprost, 1261, 1271, "travoprost", "", 
47, NumberPatientsArm, 1280, 1282, "79", "", "<http://ctro/data#Arm_74588> <http://ctro/data#hasNumberPatientsArm> \"79\"."
48, IOP, 1460, 1463, "IOP", "", 
181, RelativeTime, 1480, 1488, "10 a . m", "", 
182, Peak_IOP, 1493, 1504, "peak effect", "", 
49, TimePoint, 1510, 1518, "baseline", "", 
185, TimePoint, 1526, 1540, "months 1 and 3", "", 
50, TimePoint, 1526, 1534, "months 1", "", 
52, Caucasian, 1735, 1744, "Caucasian", "", "<http://ctro/data#Population_74566> <http://ctro/data#hasEthnicity> <http://ctro/data#Caucasian>."
41, AvgAge, 1768, 1770, "68", "", "<http://ctro/data#Population_74566> <http://ctro/data#hasAvgAge> \"68\"."
53, IOP, 1873, 1876, "IOP", "", "<http://ctro/data#Population_74566> <http://ctro/data#hasEthnicity> <http://ctro/data#Caucasian>."
54, TimePoint, 1882, 1889, "month 3", "", "<http://ctro/data#Outcome_102377> <http://ctro/data#hasTimePoint> \"month 3\". <http://ctro/data#Outcome_102404> <http://ctro/data#hasTimePoint> \"month 3\"."
55, Mean, 1896, 1900, "mean", "", "<http://ctro/data#Mean_74576> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_74574> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_74576>."
56, IOP, 1932, 1935, "IOP", "", "<http://ctro/data#IOP_74575> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_74574> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_74575>."
57, Reduction, 1988, 1993, "7 . 7", "", "<http://ctro/data#Outcome_102404> <http://ctro/data#hasChangeValue> \"7 . 7\"."
58, SdDevChangeValue, 1996, 2001, "4 . 2", "", "<http://ctro/data#Outcome_102404> <http://ctro/data#hasSdDevChangeValue> \"4 . 2\"."
61, mmHg, 2004, 2008, "mmHg", "", "<http://ctro/data#Endpoint_74574> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
63, RelativeReduction, 2011, 2017, "32 . 3", "", "<http://ctro/data#Outcome_102404> <http://ctro/data#hasRelativeChangeValue> \"32 . 3\"."
65, Brimonidine, 2027, 2038, "brimonidine", "", 
205, Brimo/TimFC, 2027, 2048, "brimonidine - timolol", "", 
66, Timolol, 2041, 2048, "timolol", "", 
60, Reduction, 2056, 2061, "6 . 7", "", "<http://ctro/data#Outcome_102377> <http://ctro/data#hasChangeValue> \"6 . 7\"."
59, SdDevChangeValue, 2064, 2069, "5 . 0", "", "<http://ctro/data#Outcome_102377> <http://ctro/data#hasSdDevChangeValue> \"5 . 0\"."
62, mmHg, 2072, 2076, "mmHg", "", 
64, RelativeReduction, 2079, 2085, "26 . 1", "", "<http://ctro/data#Outcome_102377> <http://ctro/data#hasRelativeChangeValue> \"26 . 1\"."
67, Dorzolamide, 2095, 2106, "dorzolamide", "", 
206, Dorz/TimFC, 2095, 2116, "dorzolamide - timolol", "", 
68, Timolol, 2109, 2116, "timolol", "", 
207, PvalueDiff, 2121, 2130, "= 0 . 040", "", "<http://ctro/data#DiffBetweenGroups_102431> <http://ctro/data#hasPvalueDiff> \"= 0 . 040\"."
70, Mean, 2139, 2143, "mean", "", 
106228, ProstaglandinAnalogs, 2159, 2162, "PGA", "", 
106229, SubGroupDescription, 2159, 2240, "PGA - treated baseline IOP for patients on fixed - combination adjunctive therapy", "", "<http://ctro/data#Outcome_102440> <http://ctro/data#hasSubGroupDescription> \"PGA - treated baseline IOP for patients on fixed - combination adjunctive therapy\". <http://ctro/data#Outcome_102467> <http://ctro/data#hasSubGroupDescription> \"PGA - treated baseline IOP for patients on fixed - combination adjunctive therapy\"."
209, IOP, 2182, 2185, "IOP", "", 
71, Reduction, 2245, 2250, "6 . 9", "", "<http://ctro/data#Outcome_102467> <http://ctro/data#hasChangeValue> \"6 . 9\"."
73, SdDevChangeValue, 2253, 2258, "4 . 8", "", "<http://ctro/data#Outcome_102467> <http://ctro/data#hasSdDevChangeValue> \"4 . 8\"."
75, mmHg, 2261, 2265, "mmHg", "", 
77, RelativeReduction, 2268, 2274, "29 . 3", "", "<http://ctro/data#Outcome_102467> <http://ctro/data#hasRelativeChangeValue> \"29 . 3\"."
79, Brimonidine, 2284, 2295, "brimonidine", "", 
220, Brimo/TimFC, 2284, 2305, "brimonidine - timolol", "", 
80, Timolol, 2298, 2305, "timolol", "", 
72, Reduction, 2313, 2318, "5 . 2", "", "<http://ctro/data#Outcome_102440> <http://ctro/data#hasChangeValue> \"5 . 2\"."
74, SdDevChangeValue, 2321, 2326, "3 . 7", "", "<http://ctro/data#Outcome_102440> <http://ctro/data#hasSdDevChangeValue> \"3 . 7\"."
76, mmHg, 2329, 2333, "mmHg", "", 
78, RelativeReduction, 2336, 2344, "23 . 5 %", "", 
213, RelativeReduction, 2336, 2342, "23 . 5", "", "<http://ctro/data#Outcome_102440> <http://ctro/data#hasRelativeChangeValue> \"23 . 5\"."
81, Dorzolamide, 2352, 2363, "dorzolamide", "", 
223, Dorz/TimFC, 2352, 2373, "dorzolamide - timolol", "", 
82, Timolol, 2366, 2373, "timolol", "", 
83, PValueChangeValue, 2376, 2387, "p = 0 . 213", "", 
224, PvalueDiff, 2378, 2387, "= 0 . 213", "", "<http://ctro/data#DiffBetweenGroups_102494> <http://ctro/data#hasPvalueDiff> \"= 0 . 213\"."
84, Brimonidine, 2404, 2415, "brimonidine", "", 
227, Brimo/TimFC, 2404, 2425, "brimonidine - timolol", "", 
85, Timolol, 2418, 2425, "timolol", "", 
88012, ObservedResult, 2426, 2439, "reported less", "", 
88011, EndPointDescription, 2440, 2447, "burning", "", "<http://ctro/data#EndPointDescription_102504> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_102503> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_102504>."
228, PvalueDiff, 2452, 2461, "< 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_102680> <http://ctro/data#hasPvalueDiff> \"< 0 . 001\"."
232, Stinging, 2466, 2474, "stinging", "", "<http://ctro/data#Endpoint_102508> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Stinging>."
229, PvalueDiff, 2479, 2488, "< 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_102689> <http://ctro/data#hasPvalueDiff> \"< 0 . 001\"."
88013, EndPointDescription, 2497, 2510, "unusual taste", "", "<http://ctro/data#EndPointDescription_102514> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_102513> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_102514>."
230, PvalueDiff, 2515, 2524, "< 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_102698> <http://ctro/data#hasPvalueDiff> \"< 0 . 001\"."
92, Dorzolamide, 2544, 2555, "dorzolamide", "", 
236, Dorz/TimFC, 2544, 2565, "dorzolamide - timolol", "", 
93, Timolol, 2558, 2565, "timolol", "", 
94, ConclusionComment, 2582, 2723, "Fixed - combination brimonidine - timolol provided the same or greater IOP lowering compared with fixed - combination dorzolamide - timolol .", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasConclusionComment> \"Fixed - combination brimonidine - timolol provided the same or greater IOP lowering compared with fixed - combination dorzolamide - timolol .\"."
95, Brimonidine, 2602, 2613, "brimonidine", "", 
243, Brimo/TimFC, 2602, 2623, "brimonidine - timolol", "", 
96, Timolol, 2616, 2623, "timolol", "", 
97, IOP, 2653, 2656, "IOP", "", 
98, Dorzolamide, 2700, 2711, "dorzolamide", "", 
244, Dorz/TimFC, 2700, 2721, "dorzolamide - timolol", "", 
99, Timolol, 2714, 2721, "timolol", "", 
259, ConclusionComment, 2724, 2793, "Both fixed - combination medications were safe and well - tolerated .", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasConclusionComment> \"Both fixed - combination medications were safe and well - tolerated .\"."
103, Brimonidine, 2794, 2805, "Brimonidine", "", 
249, Brimo/TimFC, 2794, 2815, "Brimonidine - timolol", "", 
260, ConclusionComment, 2794, 2886, "Brimonidine - timolol received higher ratings of ocular comfort than dorzolamide - timolol .", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasConclusionComment> \"Brimonidine - timolol received higher ratings of ocular comfort than dorzolamide - timolol .\"."
104, Timolol, 2808, 2815, "timolol", "", 
106, Dorzolamide, 2863, 2874, "dorzolamide", "", 
250, Dorz/TimFC, 2863, 2884, "dorzolamide - timolol", "", 
105, Timolol, 2877, 2884, "timolol", "", 
261, ConclusionComment, 2887, 3090, "The duration of the studies was 3 months , and additional studies will be needed to compare the efficacy and tolerability of brimonidine - timolol and dorzolamide - timolol during long - term treatment .", "", "<http://ctro/data#ClinicalTrial_74541> <http://ctro/data#hasConclusionComment> \"The duration of the studies was 3 months , and additional studies will be needed to compare the efficacy and tolerability of brimonidine - timolol and dorzolamide - timolol during long - term treatment .\"."
107, Duration, 2919, 2927, "3 months", "", 
108, Brimonidine, 3012, 3023, "brimonidine", "", 
256, Brimo/TimFC, 3012, 3033, "brimonidine - timolol", "", 
109, Timolol, 3026, 3033, "timolol", "", 
111, Dorzolamide, 3038, 3049, "dorzolamide", "", 
257, Dorz/TimFC, 3038, 3059, "dorzolamide - timolol", "", 
110, Timolol, 3052, 3059, "timolol", "", 
112, PMID, 3134, 3142, "19476406", "", "<http://ctro/data#Publication_74529> <http://ctro/data#hasPMID> \"19476406\"."
